Key facts
- Sierra Medical’s last known valuation is $6.8M (Jun 2025).
- It has raised $1.2M; the latest was Early Stage VC ($1.2M) in Jun 2025.
- Notable investors include Innovate UK, European Innovation Council, Golden Section.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Sierra Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Sierra Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sierra Medical
Developer of healthcare software designed to increase the speed and reliability of cancer detection and diagnosis. The company's platform focuses on innovation in this field by eliminating samples sent to diagnostic laboratories, which cause global delays in the fight against cancer, enabling patients to adopt a new alternative that is not as expensive, subjective, and time-consuming.
- Sector
- Healthcare
- HQ
- Rutland, United Kingdom
- Founded
- 2021
- Employees
- 5
- Website
- sierramedical.co.uk/
- Ownership
- Privately Held (backing)
Sierra Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sierra Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sierra Medical in its N-PORT filings yet. We sweep new filings monthly.